Health Care & Life Sciences » Pharmaceuticals | Tibet Rhodiola Pharmaceutical Holding Co. Ltd.

Tibet Rhodiola Pharmaceutical Holding Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,396
1,660
1,373
786
900
1,015
Cost of Goods Sold (COGS) incl. D&A
1,128
1,335
943
193
243
211
Gross Income
268
325
430
594
657
805
SG&A Expense
244
291
354
396
429
552
EBIT
23
30
74
233
227
253
Unusual Expense
-
8
7
1
48
77
Non Operating Income/Expense
1
1
28
4
23
62
Interest Expense
11
9
8
15
18
-
Pretax Income
30
26
107
222
265
253
Income Tax
6
6
16
23
27
26
Equity in Affiliates
-
-
-
-
4
8
Consolidated Net Income
24
20
91
199
234
218
Net Income
27
21
92
198
230
216
Net Income After Extraordinaries
27
21
92
198
230
216
Net Income Available to Common
27
21
92
198
230
216
EPS (Basic)
0.19
0.14
0.63
1.36
1.37
1.20
Basic Shares Outstanding
146
146
146
146
168
180
EPS (Diluted)
0.19
0.14
0.63
1.36
1.37
1.20
Diluted Shares Outstanding
146
146
146
146
168
180
EBITDA
40
47
87
288
303
327
Other Operating Expense
2
4
2
36
1
-
Non-Operating Interest Income
5
10
11
9
32
13
Minority Interest Expense
3
1
1
1
5
2

About Tibet Rhodiola Pharmaceutical Holding Co.

View Profile
Address
No. 93 Beijing Middle Road
Lhasa Tibet 850000
China
Employees -
Website http://www.xzyy.cn
Updated 07/08/2019
Tibet Rhodiola Pharmaceutical Co., Ltd. engages in the manufacture and wholesale of pharmaceutical. Its products include Chinese patent medicine, biological products and chemical medicine. The company was founded on July 14, 1999 and is headquartered at Lhasa, Tibet.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.